People · Operator
Named in public records as an officer, director or promoter · active 2014–2020 · Biotechnology, Other Health Care, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Alzheon, Inc. | — | Biotechnology | Series D+ | $172.5M | $1.6B | 2014 |
| AltheaDx, Inc. | — | Biotechnology | Series B | $51.8M | $137.3M | 2015 |
| LoneStar Heart, Inc. | — | Other Health Care | Series A | $25.2M | $84.4M | 2017 |
| Cold Genesys, Inc. | — | Pharmaceuticals | Series A | $13.6M | $135.8M | — |
David Nikodem at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Nikodem on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Olav B. Bergheim | 1 | 13 |
| Dennis Langer | 1 | 9 |
| Scott Minick | 1 | 7 |
| Wei Li | 1 | 7 |
| Hugh B. Neuharth | 1 | 7 |
| Franklin Berger | 1 | 7 |
| Magda Marquet | 1 | 6 |
| Franz Hefti | 1 | 6 |
| Raymond W. Cohen | 1 | 5 |
| Robert Silverman | 1 | 5 |
| Christopher Noel Dunn | 1 | 5 |
| CHARLES CHON | 1 | 5 |
| J. Matthew Mackowski | 1 | 4 |
| Jason Liu | 1 | 4 |
| Andrew Jackson | 1 | 4 |
| John Wu | 1 | 4 |
| Michael Aceti | 1 | 4 |
| Fan Yu | 1 | 4 |
| Jean-Pierre Sommadossi | 1 | 3 |
| Jeffrey G. Black | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.